TY - JOUR
T1 - Integration of Genetic and Clinical Risk Factors for Risk Classification of Uveitis in Patients With Juvenile Idiopathic Arthritis
AU - the CLUSTER Consortium
AU - Tordoff, Melissa
AU - Smith, Samantha L.
AU - Lawson-Tovey, Saskia
AU - Dick, Andrew D.
AU - Beresford, Michael W.
AU - Ramanan, Athimalaipet V.
AU - Hyrich, Kimme L.
AU - Morris, Andrew P.
AU - Eyre, Stephen
AU - Wedderburn, Lucy R.
AU - Bowes, John
AU - Wedderburn, Lucy R.
AU - Wanstall, Zoe
AU - Alexiou, Vasiliki
AU - Dekaj, Fatjon
AU - Jebson, Bethany R.
AU - Kartawinata, Melissa
AU - Kimonyo, Aline
AU - Hahn, Eileen
AU - Gottschalk, Genevieve
AU - Luling Feilding, Freya
AU - McNeece, Alyssia
AU - Merali, Fatema
AU - Ralph, Elizabeth
AU - Robinson, Emily
AU - Sumner, Emma
AU - Dick, Andrew
AU - Beresford, Michael W.
AU - Carlsson, Emil
AU - Fairlie, Joanna
AU - Gritzfeld, Jenna F.
AU - McClurg, Oliver
AU - Rafferty, Karen
AU - Ramanan, Athimalaipet V.
AU - Duerr, Teresa
AU - Barnes, Michael
AU - Ng, Sandra
AU - Hyrich, Kimme
AU - Eyre, Stephen
AU - Raychaudhuri, Soumya
AU - Thomson, Wendy
AU - Bowes, John
AU - Jennycloss, Jeronee
AU - Lawson-Tovey, Saskia
AU - Martin, Paul
AU - Morris, Andrew
AU - Shoop-Worrall, Stephanie
AU - Smith, Samantha
AU - Stadler, Michael
AU - Geifman, Nophar
N1 - Publisher Copyright:
© 2024 The Author(s). Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
PY - 2024/12/1
Y1 - 2024/12/1
N2 - Objective: Juvenile idiopathic arthritis (JIA)–associated uveitis (JIAU) is a serious JIA comorbidity that can result in vision impairment. This study aimed to identify genetic risk factors within the major histocompatibility complex for JIAU and evaluate their contribution for improving risk classification when combined with clinical risk factors. Methods: Data on single nucleotide polymorphisms, amino acids, and classical HLA alleles were available for 2,497 patients with JIA without uveitis and 579 patients with JIAU (female 2,060, male 1,015). Analysis was restricted to patients with inferred European ancestry. Forward conditional logistic regression identified genetic markers exceeding a Bonferroni-corrected significance (6 × 10−6). Multivariable logistic regression estimated the effects of clinical and genetic risk factors, and a likelihood ratio test calculated the improvement in model fit when adding genetic factors. Uveitis risk classification performance of a model integrating genetic and clinical risk factors was estimated using area under the receiver operator characteristic curve and compared with a model of clinical risk factors alone. Results: Three genetic risk factors were identified, mapping to HLA-DRB1, HLA-DPB1, and HLA-A. These markers were statistically independent from clinical risk factors and significantly improved the fit of a model when included with clinical risk factors (P = 3.3 × 10−23). The addition of genetic markers improved the classification of JIAU compared with a model of clinical risk factors alone (area under the curve 0.75 vs 0.71). Conclusion: Integration of a genetic and clinical risk prediction model outperforms a model based solely on clinical risk factors. Future JIAU risk prediction models should include genetic risk factors.
AB - Objective: Juvenile idiopathic arthritis (JIA)–associated uveitis (JIAU) is a serious JIA comorbidity that can result in vision impairment. This study aimed to identify genetic risk factors within the major histocompatibility complex for JIAU and evaluate their contribution for improving risk classification when combined with clinical risk factors. Methods: Data on single nucleotide polymorphisms, amino acids, and classical HLA alleles were available for 2,497 patients with JIA without uveitis and 579 patients with JIAU (female 2,060, male 1,015). Analysis was restricted to patients with inferred European ancestry. Forward conditional logistic regression identified genetic markers exceeding a Bonferroni-corrected significance (6 × 10−6). Multivariable logistic regression estimated the effects of clinical and genetic risk factors, and a likelihood ratio test calculated the improvement in model fit when adding genetic factors. Uveitis risk classification performance of a model integrating genetic and clinical risk factors was estimated using area under the receiver operator characteristic curve and compared with a model of clinical risk factors alone. Results: Three genetic risk factors were identified, mapping to HLA-DRB1, HLA-DPB1, and HLA-A. These markers were statistically independent from clinical risk factors and significantly improved the fit of a model when included with clinical risk factors (P = 3.3 × 10−23). The addition of genetic markers improved the classification of JIAU compared with a model of clinical risk factors alone (area under the curve 0.75 vs 0.71). Conclusion: Integration of a genetic and clinical risk prediction model outperforms a model based solely on clinical risk factors. Future JIAU risk prediction models should include genetic risk factors.
UR - http://www.scopus.com/inward/record.url?scp=85211433772&partnerID=8YFLogxK
U2 - 10.1002/art.42955
DO - 10.1002/art.42955
M3 - Article
C2 - 39030878
AN - SCOPUS:85211433772
SN - 2326-5191
VL - 76
SP - 1789
EP - 1796
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
IS - 12
ER -